Oric Pharmaceuticals

ORIC

Capitalización de mercado USD 815 M

#	Nombre	Posición	Valor operado	Cambio en acciones	Cambio en la participación
1	1 Nextech Invest Zurich, Switzerland	USD 58.6 M	–	–	–
2	2 EcoR1 Capital San Francisco, California	USD 55 M	–	–	–
3	3 Viking Global Investors Stamford, Connecticut	USD 53.8 M	-USD 104	-9	-0%
4	4 BlackRock New York	USD 48.1 M	+USD 6.89 M	+598,433	+11%
5	5 VR Adviser New York	USD 46.4 M	-USD 10.6 M	-920,655	-14%
6	6 Pfizer New York	USD 44 M	–	–	–
7	7 SR One Capital Management Wayne, Pennsylvania	USD 37.8 M	–	–	–
8	8 Vanguard Group Malvern, Pennsylvania	USD 37.2 M	-USD 1.25 M	-108,164	-2%
9	9 Alkeon Capital Management New York	USD 36.8 M	–	–	–
10	10 State Street Boston, Massachusetts	USD 34.8 M	+USD 21.3 M	+1,854,458	+77%
11	11 NEA Management Company Timonium, Maryland	USD 33.7 M	–	–	–
12	12 OrbiMed New York	USD 29.8 M	–	–	–
13	13 Column Group San Francisco, California	USD 29 M	–	–	–
14	14 T. Rowe Price Associates Baltimore, Maryland	USD 27 M	+USD 4.88 M	+423,795	+15%
15	15 Point72 Asset Management Stamford, Connecticut	USD 23.9 M	+USD 3.49 M	+303,163	+12%
16	16 Fidelity Investments Boston, Massachusetts	USD 20.3 M	-USD 565 k	-49,126	-2%
17	17 Citadel Advisors Miami, Florida	USD 19.9 M	+USD 14.2 M	+1,236,706	+103%
18	18 Paradigm Biocapital Advisors New York	USD 19.6 M	+USD 27.6 M	+2,401,217	Nuevas
19	19 Vivo Capital Palo Alto, California	USD 17.3 M	-USD 11.6 M	-1,008,220	-32%
20	20 First Turn Management Del Mar, California	USD 16.4 M	-USD 1.72 M	-149,167	-7%
21	21 Goldman Sachs New York	USD 15.9 M	+USD 11.9 M	+1,034,473	+114%
22	22 MPM BioImpact Boston, Massachusetts	USD 14.7 M	+USD 798 k	+69,339	+4%
23	23 Geode Capital Management Boston, Massachusetts	USD 14.3 M	+USD 1.38 M	+119,950	+7%
24	24 Royce & Associates New York	USD 12.3 M	+USD 562 k	+48,818	+3%
25	25 Dimensional Fund Advisors Austin, Texas	USD 10 M	+USD 4.99 M	+433,359	+55%

Oric Pharmaceuticals ORIC Capitalización de mercado USD 815 M

Oric Pharmaceuticals

ORIC

Capitalización de mercado USD 815 M